As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.
“We have a plan to make the post-production work on cut flowers and greens significantly faster and more efficient than what's being done currently.”
"In our extensive market research, this was an area that we immediately targeted for innovation," said NTRR CEO Sydney Jim. "We have a plan to make the post-production work on cut flowers and greens significantly faster and more efficient than what's being done currently."
Variations in the care and handling of plants can make it difficult for patients to accurately predict the benefits they will receive from cannabis from strain to strain and dispensary to dispensary. To solve this problem, NTRR formed a new joint venture with Vertigo Technologies to advance the development and marketing of innovative horticulture systems that could soon benefit a variety of plant-based businesses.
It's the next step in the company's plans to capture a share of the booming $1.7 billion medical marijuana (MMJ) market in the U.S. by delivering advanced technology to improve production quality and efficiency in the nascent industry. NTRR and Vertigo expect to deliver a working prototype within a short time frame.
Through its subsidiary, Cannabis Technologies, NTRR is working to help introduce the next wave of healthier, more efficient delivery systems to the ever-growing MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
Study links cannabis use to genotoxicity and transgenerational health impacts